Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Filgrastim (Leuco-Plus 300) for Prevention of Chemotherapy-Induced Neutropenia in Diffuse Large B-Cell Lymphoma
TCTR20170802002Phase 4Terminated
- Sponsor
- Apexcela
- Start
- Aug 2017
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of filgrastim in diffuse large B-cell lymphoma (DLBCL), sponsored by Apexcela. Started Aug 2017; status: terminated.
02
Drugs
filgrastim
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on TCTR20170802002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170802002.